|Min SIP Amount||₹1000|
|NAV||₹49.19 (22 Jan 2021)|
|Fund Started||12 Dec 2006|
|Fund Size||₹7 Cr|
|Sun Pharmaceutical Inds. Ltd.||Healthcare||Equity||8.6%|
|Fortis Healthcare (India) Ltd||Healthcare||Equity||8.3%|
|Adani Ports and Special Economic Zone Ltd.||Services||Equity||8.1%|
|Bharti Airtel Ltd.||Communication||Equity||8.1%|
|HCL Technologies Ltd.||Technology||Equity||6.9%|
|Alembic Pharmaceuticals Ltd.||Healthcare||Equity||6.2%|
|Adani Enterprises Ltd.||Services||Equity||5.9%|
|Hindustan Unilever Ltd.||FMCG||Equity||5.3%|
|Divi's Laboratories Ltd.||Healthcare||Equity||4.7%|
Quant Large and Mid Cap Fund Growth is a Equity Mutual Fund Scheme launched by Quant Mutual Fund. This scheme was made available to investors on 12 Dec 2006. Sanjeev Sharma is the Current Fund Manager of Quant Large and Mid Cap Fund Growth fund.The fund currently has an Asset Under Management(AUM) of ₹7 Cr and the Latest NAV as of 22 Jan 2021 is ₹49.19.
The Quant Large and Mid Cap Fund Growth is rated Moderately High risk. Minimum SIP Investment is set to 1000. Minimum Lumpsum Investment is 5000.
The scheme seeks to provide capital appreciation by investing in a portfolio of Large and Midcap companies.
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.